CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan

por Blume, Joshua, Claus, Luisa, Isermann, Tamara, Dickmanns, Antje, Conradi, Lena-Christin, Schulz-Heddergott, Ramona, Dobbelstein, Matthias
Publicado 2023

Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity

por Isermann, Tamara, Şener, Özge Çiçek, Stender, Adrian, Klemke, Luisa, Winkler, Nadine, Neesse, Albrecht, Li, Jinyu, Wegwitz, Florian, Moll, Ute M., Schulz-Heddergott, Ramona
Publicado 2021